GSK-364735 Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections / Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00398125 | Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults |